Renal Disease Market Highlights
The global renal disease market is expected to register a CAGR of 6.32% during the forecast period with a market value of USD 93,375.70 million in 2017. Renal diseases can be classified as chronic kidney disease (CKD) and end-stage renal disease (ESRD). Renal diseases may cause kidney failure. When CKD worsens, it eventually leads to ESRD. As per the National Institute of Diabetes and Digestive and Kidney Disease Report 2015, more than 6,61,000 Americans had kidney failure.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/3167
The rising prevalence of kidney diseases, diabetes, hypertension and rapid growth in the geriatric population have led to the growth of the global renal disease market in recent years. However, rising healthcare costs and stringent regulatory policies are likely to restrain market growth over the forecast period.
Renal Disease Market Segmentation
The global renal disease market has been segmented based on type, diagnosis, and treatment. By type, the market has been segmented into acute kidney problems, chronic kidney diseases, and others. The acute kidney problems segment has been further segmented into Prerenal, Post renal, and Renal. By diagnosis, the market has been segmented into Blood tests, Urine tests, imaging tests, removing a sample of kidney tissue for testing, and others. The blood tests segment has been further segmented into Serum Creatinine, Glomerular Filtration Rate (GFR), Blood Urea Nitrogen (BUN), and fasting blood glucose test. The urine test segment has been further segmented into Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test. The imaging test segment has been further segmented into ultrasound and CT scan. By treatment, the market has been segmented into Medications, Dialysis, Kidney transplant, Surgery, Diet and others. The medication segment has been further segmented into High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, and Medications to protect your bones. The dialysis segment has been further segmented into Hemodialysis, and Peritoneal dialysis. The kidney transplant segment has been further segmented into Deceased-donor kidney transplant, Living-donor kidney transplant, and Pre-emptive kidney transplant. The surgery segment has been further segmented into Nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy, extracorporeal shock wave lithotripsy (ESWL), and others.
Renal Disease MarektRegional Analysis
The global renal disease market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas account for the largest share of the global renal disease market followed by Europe. The America market for renal disease is dominated by the US owing to high health care spending, favorable reimbursement scenario and the presence of a large patient population in the region. Europe market is going strong on account of a robust healthcare sector and availability of funds for R&D. Germany, France, Italy, UK, and Spain are the key contributors to the Europe market for renal diseases. Asia Pacific is expected to grow at a relatively faster rate, led by Japan, China, India, and South Korea. The Middle East & Africa market is expected to exhibit moderate growth over the forecast period and will be led by the Gulf economies of UAE, Saudi Arabia, and others.
Competitive Landscape
The key players in the global renal disease market include Abbott (US), Baxter (US), Keryx Biopharmaceuticals, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Amgen Inc. (US), Bristol-Myers Squibb Company (US), NephroGenex, Inc. (US), Pfizer Inc.(US), Shire Pharmaceuticals Limited (Republic of Ireland), and others.
Industry Updates
In August 2018, Nephros subsidiary Specialty Renal Products (SRP) agreed with HemoCleanse Technologies to develop and commercialize rights for a dialysate regeneration and filtration system for the treatment of renal disease. According to the agreement, SRP will be the manufacturer of record for licensors of the technology outside of renal disease.
Table Of Contents
1 Executive Summary
2 Market Introduction
2.1 Scope Of Study
2.2 Research Objective
2.3 List Of Assumptions
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Prevalence Of Kidney Disease
4.2.1 Growing Prevalence Of Diabetes And Hypertension
4.2.2 Rapid Growth In The Geriatric Population
4.3 Restraints
4.3.1 Rising Healthcare Cost
4.3.2 Stringent Regulatory Policies
4.4 Opportunities
4.4.1 Expansion In Developing Economies
4.5 Market Trends
4.5.1 Artificial Intelligence (AI) For Managing And Diagnosis Of Chronic Kidney Disease (CKD)
4.6 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
Continued…
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/renal-disease-market-3167
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
